INDOUS80.34

Indo Us Biotech Limited

· FMCG & Retail
₹ CrorePeersKOHINOORNATHBIOGENAGRITECHSARVESHWARSUKHJITSREGAALBSHSLGULPOLYMcap ₹161 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity20.7214.1814.18
Return on Assets16.639.869.86
Return on Capital Employed21.8817.2217.22
Return on Invested Capital18.8512.3015.25
Margins
EBITDA Margin18.2315.4014.62
Operating Margin17.1814.5914.59
Incremental Operating Margin-26.17
Pretax Margin15.9212.6011.85
Net Income Margin15.6711.8811.27
FCF Margin-1.37-12.38-12.38
Additional
Effective Tax Rate1.595.734.92
Dvd Payout Ratio3.080.00
Sustainable Growth Rate20.0814.1814.18
Incremental Operating Margin %-26.1711.19
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.